Loading...
Loading...
Among the 9 tracked institutional investors we monitor, RYTM (RHYTHM PHARMACEUTICALS INC) is held with a combined value of $2.30B across 25,023,728 shares. The largest holder is VANGUARD GROUP INC with a position worth $664.82M (0.01% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 4 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$2.30B
Total Shares Held
25,023,728
Institutional Holders
9
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $664.82M | 0.01% | New |
| 2 | BlackRock, Inc. | $542.45M | 0.01% | -1.0% |
| 3 | BAKER BROS. ADVISORS LP | $487.42M | 2.80% | - |
| 4 | STATE STREET CORP | $197.58M | 0.01% | +3.3% |
| 5 | FMR LLC | $146.95M | 0.01% | -1.0% |
| 6 | CITADEL ADVISORS LLC | $126.37M | 0.02% | +659.9% |
| 7 | Point72 Asset Management, L.P. | $73.65M | 0.09% | +97.2% |
| 8 | MILLENNIUM MANAGEMENT LLC | $39.30M | 0.02% | +142.0% |
| 9 | RENAISSANCE TECHNOLOGIES LLC | $22.44M | 0.04% | -24.4% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of RYTM with a position worth $664.82M, representing 0.01% of their portfolio. In total, 9 institutional investors hold RYTM with a combined value of $2.30B.
In the most recent quarter, 1 fund opened a new position in RYTM. Additionally, 4 increased their holdings and 3 reduced their positions.
Institutional investors hold $2.30B worth of RYTM stock across 9 positions. The largest institutional holder is VANGUARD GROUP INC with $664.82M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For RYTM, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their RYTM positions.